Latest stories on HLP
Helus Pharma Completes Enrollment in Phase 3 APPROACH Study of HLP003 in Adjunctive Treatment of Major Depressive Disorder Ahead of Schedule
Business Insider63 · neutralproduct/pr
Hongli Group Faces Nasdaq Minimum Bid Price Deficiency, Given 180 Days to Regain Compliance
TipRanks34 · bearishgeneral
Hongli Group receives Nasdaq deficiency notice after shares fall below $1 rule
Seeking Alpha34 · bearishgeneral
Hongli Group Inc. Receives Nasdaq Notice Regarding Minimum Bid Price Deficiency | HLP Stock News
StockTitan34 · bearishgeneral
Hongli Group Names Li Li to Board and Key Governance Committees
TipRanks55 · neutralgeneral
GAAP EPS of $0.03, revenue of $19.6M
Seeking Alpha59 · neutralearnings